Latest News

MEI Pharma Reports First Quarter Fiscal Year 2021 Results and Operational Highlights
MEI Pharma to Present at Two Upcoming Investor Healthcare Conferences
Kyowa Kirin and MEI Pharma Announce First Patient Dosed in Japanese Pivotal Phase 2 Study of Zandelisib in Patients with Indolent B-cell non-Hodgkin's Lymphoma
MEI Pharma Appoints Brian T. Powl As Senior Vice President, Marketing